Last reviewed · How we verify

Carbon-11 labeled Acetate

Daniel Vaena · Phase 1 active Small molecule Quality 0/100

Carbon-11 labeled Acetate is a Small molecule drug developed by Daniel Vaena. It is currently in Phase 1 development. Also known as: C-11 Acetate; Acetate.

At a glance

Generic nameCarbon-11 labeled Acetate
Also known asC-11 Acetate; Acetate
SponsorDaniel Vaena
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Carbon-11 labeled Acetate

What is Carbon-11 labeled Acetate?

Carbon-11 labeled Acetate is a Small molecule drug developed by Daniel Vaena.

Who makes Carbon-11 labeled Acetate?

Carbon-11 labeled Acetate is developed by Daniel Vaena (see full Daniel Vaena pipeline at /company/daniel-vaena).

Is Carbon-11 labeled Acetate also known as anything else?

Carbon-11 labeled Acetate is also known as C-11 Acetate; Acetate.

What development phase is Carbon-11 labeled Acetate in?

Carbon-11 labeled Acetate is in Phase 1.

Related